Seres Therapeutics logo
Seres Therapeutics MCRB
$ 0.92 10.44%

Quarterly report 2024-Q2
added 08-13-2024

report update icon

Seres Therapeutics Operating Income 2011-2024 | MCRB

Annual Operating Income Seres Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-108 M -246 M -64.5 M -88.1 M -71.9 M -100 M -91.4 M -92.8 M -54.9 M -15.1 M -6.05 M - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-6.05 M -246 M -85.4 M

Quarterly Operating Income Seres Therapeutics

2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-31.3 M -39.6 M - -47.4 M 49.5 M -70.6 M - -59.1 M -63.3 M -55.8 M - 68.4 M -48.1 M -35.3 M - -30 M -20.5 M -19.7 M -19.2 M -17.2 M -10.9 M -24.6 M -21.7 M -22.2 M -28.1 M -28.3 M -29.8 M -7.31 M -28.4 M -25.9 M -25.7 M -19.1 M -28.1 M -19.9 M -19.8 M -14.6 M -12.3 M -8.17 M -7.21 M -3.58 M -2.62 M -1.67 M - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
68.4 M -70.6 M -21.8 M